Available 24/7 (877) 245-6707

Daiichi Sankyo Corporation’s Patent for Benicar Expires in 2016

Posted on May 24, 2016

Concerns over the dangerous side effects associated with the use of Benicar (olmesartan medoxomil) have not kept the medication from being one of the most prescribed angiotensin receptor blockers, or ARBs, on the market. Annually, Benicar pulls in a whopping $2 billion in sales. ARBs are a category of high blood pressure medications that includes Novartis and Diovan. Daiichi Sankyo’s patent for Benicar is set to expire this year (2016), and several manufacturers of generic pharmaceuticals are anxious to produce their own versions of the drug. Mylan Pharmaceuticals has already secured the right to exclusively sell the medication for the first 180 days after the patent expires.

The pharmaceutical industry is eager to exploit Benicar and its generic version, even though serious questions still linger regarding the medication’s link to birth defects and the development of heart disease in patients with diabetes. Benicar has also been shown to cause severe diarrhea, extreme weight loss, and intestinal malabsorption (which can lead to malnutrition). It is also recommended that patients with a history of congestive heart failure, liver disease, or dehydration not take Benicar.

If you were prescribed Benicar for any length of time and experienced any adverse side effects, you may be entitled to compensation for any damages you suffered. These could include medical bills, pain and suffering, permanent injury or disability, lost wages from missed work, and more. But Daiichi Sankyo is a large, powerful corporation, Japan’s second biggest pharmaceutical manufacturer, and they aren’t going to just hand you a check. If you intend to have a successful legal claim against a gigantic corporation, you need the representation of a highly skilled pharmaceutical litigation attorney.

Contact Farah & Farah

The legal team at Farah & Farah has been fighting or the rights of injured people for over 35 years. We are not intimidated by large corporations with deep pockets. Farah & Farah is currently investigating injuries related to Benicar use nationwide. Call Farah & Farah today for a free consultation at (800) 533-3555.